Search Within

Kaitlyn Ruth Shank

Formats
  1. Journal Article (10)
  2. Meeting Abstract (9)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (20)
  2. Center for Hematologic Malignancies (20)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (20)
  4. Department of Medicine (20)
  5. Executive Committee, Center for Hematologic Malignancies (20)
  6. GSK Faculty (20)

More Groups

People
  1. Ross Levine (20)
  2. Alan Shih (9)
  3. Franck Rapaport (9)
  4. Matthew Keller (9)
  5. Barbara Spitzer (7)
  6. Efthymia Papalexi (5)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (2)
  4. 2016 (3)
  5. 2015 (6)
  6. 2014 (4)

More Years

Publications
  1. Blood (10)
  2. Cancer Cell (3)
  3. Haematologica (2)
  4. Cancer Discovery (1)
  5. Journal of Clinical Investigation (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Cell Press (3)
  3. Ferrata Storti Foundation (2)
  4. Nature Publishing Group (2)
  5. American Association for Cancer Research (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms
    Research Letter

    Shank, K.; Dunbar, A.; Koppikar, P.; Kleppe, M.; Teruya-Feldstein, J.; Csete, I.; Bhagwat, N.; Keller, M.; Kilpivaara, O.; Michor, F.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Journal Article

    Kunimoto, H.; Meydan, C.; Nazir, A.; Whitfield, J.; Shank, K.; Rapaport, F.; Maher, R.; Pronier, E.; Meyer, S. C.; Garrett-Bakelman, F. E.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
    Journal Article

    McKenney, A. S.; Lau, A. N.; Hanasoge Somasundara, A. V.; Spitzer, B.; Intlekofer, A. M.; Ahn, J.; Shank, K.; Rapaport, F. T.; Patel, M. A.; Papalexi, E.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells
    Journal Article

    Kunimoto, H.; McKenney, A. S.; Meydan, C.; Shank, K.; Nazir, A.; Rapaport, F.; Durham, B.; Garrett-Bakelman, F. E.; Pronier, E.; Shih, A. H.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Combination targeted therapy to disrupt aberrant oncogenic signaling and reverse epigenetic dysfunction in IDH2- and TET2-mutant acute myeloid leukemia
    Journal Article

    Shih, A. H.; Meydan, C.; Shank, K.; Garrett-Bakelman, F. E.; Ward, P. S.; Intlekofer, A. M.; Nazir, A.; Stein, E. M.; Knapp, K.; Glass, J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Meeting Abstract

    Kunimoto, H.; Meydan, C.; Nazir, A.; Shank, K.; Maher, R.; Rapaport, F.; Pronier, E.; Melnick, A.; Levine, R. L.; Shih, A. H.
    Blood (2016)

    Fulltext@MSK | Save
  • DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
    Journal Article

    Guryanova, O. A.; Shank, K.; Spitzer, B.; Luciani, L.; Koche, R. P.; Garrett-Bakelman, F. E.; Ganzel, C.; Durham, B. H.; Mohanty, A.; Hoermann, G.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
    Journal Article

    Guryanova, O. A.; Lieu, Y. K.; Garrett-Bakelman, F. E.; Spitzer, B.; Glass, J. L.; Shank, K.; Martinez, A. B. V.; Rivera, S. A.; Durham, B. H.; Rapaport, F.; more...
    Leukemia (2016)

    Fulltext@MSK | Save
  • Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
    Meeting Abstract

    Viny, A. D.; Ott, C. J.; Spitzer, B.; Rivas, M. A.; Meydan, C.; Papalexi, E.; Yelin, D.; Shank, K.; Reyes, J.; Chiu, A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Lysine-specific histone demethylase, LSD1, (KDM1A) as a novel therapeutic target in myeloproliferative neoplasms
    Meeting Abstract

    Kleppe, M.; Shank, K.; Papalexi, E.; Riehnhoff, H.; Levine, R. L.
    Blood (2015)

    Fulltext@MSK | Save